Private Call and Webcast Available Only to Shareholders of Record
VANCOUVER, July 25, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will
host a conference call and webcast to review its results for the second
quarter ended June 30, 2013 on Thursday, August 8, 2013 at 1:00 PM ET
(10:00 AM PT). The call and webcast will be available only to existing
holders of Angiotech common stock, and only current shareholders of
record will be eligible to receive financial and certain other company
information. Shareholders of Angiotech will receive a notice via
Computershare in advance of August 8 that will provide the details of
how to attend the conference call.
As of May 2013, subsequent to the sale of Angiotech's Interventional
Products Business to Argon Medical Devices, Inc. and the retirement of
all outstanding long-term debt obligations, Angiotech became a fully
private company, and therefore is no longer a voluntary filer of its
financial information with the U.S. Securities and Exchange Commission.
Prospective purchasers of Angiotech shares in the secondary market may
be eligible to receive financial or other information through the
execution of a formal non-disclosure agreement. The execution of any
non-disclosure agreement and the subsequent provision of financial or
other company information will be at the sole discretion of Angiotech.
©2013 Angiotech Pharmaceuticals, Inc. All Rights Reserved.
Angiotech develops, manufactures and markets medical device products and
technologies, primarily within the areas of wound closure and
ophthalmology. Our strategy is to utilize our precision manufacturing
capabilities and our highly targeted sales and marketing capabilities
to offer novel or differentiated medical device products to patients,
physicians and other medical device manufacturers or distributors.
SOURCE Angiotech Pharmaceuticals, Inc.